Font Size: a A A
Keyword [Everolimus]
Result: 1 - 20 | Page: 1 of 4
1. Synergistic And Drug Resistance Of PI3K / AKt / MTOR Signaling Pathway In Gastric
2. Effects And Mechanisms Of Combined Treatment With Everolimus And Gefitinib On Non-small Cell Lung Cancer Cell Lines
3. Everolimus Is More Effective Than Rapamycin In Treating Diabetic Nephropathy In A Diabetic Mouse Model
4. K-Ras Mutation Induced Feedback ERK Activation Contributes To The Everolimus Resistance In Pancreatic Cancer
5. Knockdown Of Med19by Lentivirus-mediated ShRNA In Human Osteosarcoma Cells Inhibits Cell Proliferation Everolimus Resistance In Pancreatic Cancer
6. Combination Of Rad001(Everolimus) And Propachlor Synergistically Induces Apoptosis Through Enhanced Autophagy In Prostate Cancer Cells
7. Target Of Rapamycin Inhibitors (Sirolimus And Everolimus) Protocol Versus Cyclosporine Protocol For Initial Immunosuppression Of Kidney Transplatation Recipients: A Meta-analysis Of Randomized Trials
8. Efficacy And Safety Of MTOR Inhibitor For Early-stage ADPKD Patients: A Meta-analysis Of Randomized Controlled Trials
9. Effect Of Everolimus Of Vascular Restenosis In Rats With Injured Carotid Artery By Balloon
10. Effect Of Everolimus On The Neointimal Growth In Rats With Injured Carotid Artery By Balloon
11. The Role Of Molecular Pathogenesis Of The Activation Of PI3K/AKT/mTOR Signaling Pathway And The Pre-clinical Study Of Targeted Therapy In Diffuse Large B Cell Lymphoma
12. The New Molecular Targets Of Adrenal Malignant Tumor
13. The MTOR Pathway Inhibitor Everolimus In Vivo Studies Of The Different Glioma Cell Autophagy And Cell Cycle
14. 1.Clinical Research Of Everolimus In The Treatment Of Metastatic Renal Cell Carcinoma2.Clinical Application Of Laparoscopic Technique In The Treatment Of Retroperitoneal Fibrosis
15. Experimental Study Of IL-15and MTOR Inhibitor In The Treatment Of Breast Cancer Of Mice
16. The Drug Sensitivity Research Of Breast Cancer Stem Cells On Targeted-, Chemo-and Endocrine-Therapy
17. Everolimus-eluting Versus Sirolimus-eluting Stents For Treatment Of Coronary Atherosclerotic Heart Disease:a Meta-analysis
18. The Effect And Mechanism Of Blocking EGFR And MTOR Signaling Pathway In Nasopharyngeal Carcinoma Resistant To EGFR-TKI
19. Study The Relationship Between PI3K/AKT/mTOR Signaling Pathways And The Intrinsic Resistance Of Nasopharyngeal Carcinoma CNE1-LMP1Cells To Gefitinib
20. Research On Prevention Of Everolimus Associated With Pravastatin On Allograft Angiopathy In Rats
  <<First  <Prev  Next>  Last>>  Jump to